Trials / Completed
CompletedNCT04014153
CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?
The Impact of Comorbidity as a Risk Factor of Acute Kidney Injury (AKI) in Patients With Stable Coronary Artery Disease (CAD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,023 (actual)
- Sponsor
- I.M. Sechenov First Moscow State Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- —
Summary
Patients aged 18-89 with stable CAD and comorbidities receiving optimal medical treatment requiring PCI with iodinated contrast media. The aim of the study is to assess the prevalence of contrast-induced AKI in 2012-2013 and 2017 cohorts and to evaluate the potential risk factors of CI-AKI to better guide the prevention in patients of higher risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Iodinated contrast media | Percutaneous coronary intervention with iodinated contest media |
Timeline
- Start date
- 2012-05-16
- Primary completion
- 2017-10-19
- Completion
- 2018-12-12
- First posted
- 2019-07-10
- Last updated
- 2019-10-29
Source: ClinicalTrials.gov record NCT04014153. Inclusion in this directory is not an endorsement.